These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38698580)

  • 21. Time for a New Perspective on Prolactin in Metabolism.
    Macotela Y; Triebel J; Clapp C
    Trends Endocrinol Metab; 2020 Apr; 31(4):276-286. PubMed ID: 32044206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with primary hypothyroidism presenting as prolactinomas.
    Grubb MR; Chakeres D; Malarkey WB
    Am J Med; 1987 Oct; 83(4):765-9. PubMed ID: 3674063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic-pituitary function and radiographic evaluation of women with hyperprolactinemia and an "empty" sella turcica.
    Haney AF; Kramer RS; Wiebe RH; Hammond CB
    Am J Obstet Gynecol; 1979 Aug; 134(8):917-24. PubMed ID: 463996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
    Khorassanizadeh R; Sundaresh V; Levine SN
    World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging.
    Kawaguchi T; Ogawa Y; Tominaga T
    BMC Res Notes; 2014 Aug; 7():555. PubMed ID: 25142896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of adipose tissue and liver radiodensity in overweight or obese patients with nonalcoholic fatty liver disease.
    Kempiński R; Neubauer K; Hałoń A; Podgórski P; Dudkowiak R; Poniewierka E
    Pol Arch Intern Med; 2019 May; 129(5):354-356. PubMed ID: 30793706
    [No Abstract]   [Full Text] [Related]  

  • 32. Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome.
    Malarkey WB; Goodenow TJ; Lanese RR
    Am J Med; 1980 Dec; 69(6):886-90. PubMed ID: 7192490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter to the editor: diagnosing fibrosis and cirrhosis in nonalcoholic fatty liver disease using machine learning models.
    Feng Y; Peng B; Li Y; Sun L; Sun Y
    Hepatology; 2023 May; 77(5):E103-E104. PubMed ID: 36645222
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.
    Ji D; Zhang M; Qin E; Zhang L; Xu J; Wang Y; Cheng G; Wang F; Lau G
    Metabolism; 2021 Feb; 115():154437. PubMed ID: 33220249
    [No Abstract]   [Full Text] [Related]  

  • 35. [Endocrine disorders in "empty" sella turcica].
    Mizetskaia EA; Snigireva RIa
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (6):12-7. PubMed ID: 6528785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Calzadilla-Bertot L; Jeffrey AW; Jeffrey GP
    Hepatology; 2024 Jun; 79(6):E153-E154. PubMed ID: 38349675
    [No Abstract]   [Full Text] [Related]  

  • 37. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity.
    Ferreira S; Mendes J; Couto D; Ferreira D; Rêgo C
    Acta Med Port; 2024 Mar; 37(3):177-186. PubMed ID: 38330918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical diagnosis in prolactinomas: some caveats.
    Petersenn S
    Pituitary; 2020 Feb; 23(1):9-15. PubMed ID: 31873848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia.
    Lissoni P; Mainini E; Mazzi C; Cattaneo G; Barni S
    J Endocrinol Invest; 1990 Feb; 13(2):85-9. PubMed ID: 2329263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.